APTBIO, a Shanghai-based proteomic technology firm, recently announced that it has completed a RMB200 million (US$28.29 million) series A round of financing, led by Luxin Venture Capital and Wuxi New District Investment Group. The proceeds from this round of financing will be mainly used for the construction of mass spectrometry platform and supercomputing center, precision […] Chinese Proteomic Technology Firm APTBIO Raises $28M In New Round comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.